RxSight, Inc. 1,785,714 Shares of Common Stock, par value $0.001 per share Underwriting AgreementRxSight, Inc. • May 9th, 2024 • Ophthalmic goods • New York
Company FiledMay 9th, 2024 Industry JurisdictionRxSight, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 1,785,714 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 267,857 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”